Introduction
Ependymomas are rare forms of primary brain tumors, accounting for 3-7% of all brain tumors [1, 2] . Ependymomas, composed of neoplastic ependymal cells, are thought to arise from the ependymal cells in the ventricular system. The majority occur infratentorially in the pediatric population, while a smaller fraction occurs in adults, usually in the spinal cord [1] . Rare variants of ependymomas have been described and can include cellular, papillary, clear-cell, and tanycytic variants. Tanycytic ependymomas are particularly rare and typically occur in the spinal cord as an intramedullary mass. First described by Friede and Pollak [3] in 1978, tanycytic ependymoma represents a WHO grade II ependymoma with characterized pathology described as containing bipolar cells with absent mitosis and low-to-moderate cellularity. Here we report a case of a supratentorial intraparenchymal tanycytic ependymoma.
The patient is a 58-year-old male with a history of hypertension and type II diabetes mellitus who presented to an outside hospital after developing chin and right arm tremors, followed by a seizure. The seizure was complicated by a fall and urinary incontinence; the seizure resolved on its own. A CT completed at an outside hospital revealed a large, complex cystic mass in the frontal lobe and left hemispheric subarachnoid hemorrhage. The patient was administered levetiracetam and transferred to a specialty hospital for further evaluation. MRI analysis revealed a 5.6 × 8 × 5 cm complex cystic lesion in the left frontoparietal lobe, with a mass effect on the left lateral ventricle ( fig. 1 ). This lesion included several nodular T2 bright and T1 isointense solid components. There was some enhancement in the cystic components that was also visualized on T1 imaging with gadolinium. Surgery was performed, and a left frontoparietal brain lesion, which was initially suspected to be a low-grade glioma, was removed. However, the tumor was surprising in its grayness and more firm than it would be expected for a low-grade glioma. The surgery was repeated 3 days later for microdissection and tissue harvesting. During his hospital stay, the patient developed waxing and waning expressive aphasia, with the development of global aphasia, a right facial droop, and right-sided weakness. A CT demonstrated hemorrhage in the resection cavity, effacement of the left superior frontoparietal sulci suggestive of cerebral edema, and a slight increase in left to right midline shift from 1.3 to 1.5 cm. This required surgery on postoperative day 6 for removal. However, it was unclear if the aphasia stemmed from the clot or cerebral edema following the surgery. On the day following evacuation of the hematoma, the patient's symptoms improved. The patient's symptoms included residual slurred speech, which improved over the subsequent month. At his last visit, 18 months following surgery, he continued to do well with no evidence of clinical or radiographic recurrence.
Pathological analysis revealed brain tissue infiltrated by well-differentiated piloid cells with low-to-moderate cellularity ( fig. 2 ). There was no microvascular proliferation or necrosis identified. Analysis of immunohistochemical staining revealed glial fibrillary acidic protein-positivity solely in reactive astrocytes. The proliferative index of the tumor was low, with only 2% of cells positive for Ki67 staining. Immunohistochemistry was also negative for mutant isocitrate dehydrogenase 1 (IDH1 R132H ). Immunohistochemistry against epithelial membrane antigen revealed a 'dot-like' positivity. A histological analysis revealed a tanycytic ependymoma (WHO Grade II).
Discussion
This case report shows the diagnosis and current clinical outcome of a male adult patient with a supratentorial tanycytic ependymoma, WHO grade II. This rare variant of ependymoma commonly occurs in the spinal cord. In a review of the literature, we identified only 6 cases of ectopic supratentorial tanycytic ependymomas (table 1) [4] [5] [6] [7] [8] [9] . All patients were male, and their ages ranged from 2 to 59 years. Four cases were identified after the onset of seizures, one after the onset of headaches, and one was incidental. Locations varied among the cases, including both cortical and subcortical locations as well as right and left hemispheres. Tumors were frontal, temporoparietal, temporo-occipital, parietal, and parietooccipital. In this series of patients, surgery was the primary treatment modality with no utilization of further radiotherapy or chemotherapy. The wide age ranges of the patients and the presence of the tumors throughout the hemispheres underscore the importance of considering ependymomas in the diagnosis of tumors occurring throughout the brain. This is espe- 
